CACHEXIA; CANCER
Clinical trials for CACHEXIA; CANCER explained in plain language.
Never miss a new study
Get alerted when new CACHEXIA; CANCER trials appear
Sign up with your email to follow new studies for CACHEXIA; CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection aims to reverse wasting in cancer patients
Symptom relief Not yet recruitingThis early-stage study tests a new drug called GB18 in people with advanced cancer who are losing weight and muscle (cachexia). The drug targets a protein linked to appetite loss. About 18 to 36 adults will receive multiple doses to see if it is safe and helps them gain weight an…
Matched conditions: CACHEXIA; CANCER
Phase: PHASE1 • Sponsor: Kexing Biopharm Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 12:05 UTC
-
Gut health boost may fight cancer wasting in lung patients
Symptom relief Not yet recruitingThis study tests whether an oral postbiotic called JK-5G can help non-small-cell lung cancer patients with cachexia—a condition causing severe weight loss and muscle wasting. About 150 adults with advanced lung cancer will receive either JK-5G or a placebo for 12 weeks. The main …
Matched conditions: CACHEXIA; CANCER
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
Poop pills for cancer wasting? new trial tests gut bacteria fix
Symptom relief Not yet recruitingThis study tests whether transplanting healthy gut bacteria (fecal microbiota transplantation) can help advanced cancer patients who are losing weight and appetite. About 66 adults with stomach, colorectal, or lung cancer will receive the treatment. The goal is to see if it impro…
Matched conditions: CACHEXIA; CANCER
Phase: PHASE2 • Sponsor: Hua Jiang • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
New drug aims to reverse Cancer-Related wasting
Symptom relief Not yet recruitingThis study tests a new drug called ASCA101 for cachexia, a condition where people with cancer lose weight and muscle. About 135 adults with certain solid tumors will receive ASCA101, an active control, or a placebo for 12 weeks. The main goal is to see if the drug helps increase …
Matched conditions: CACHEXIA; CANCER
Phase: PHASE2 • Sponsor: MetaFines • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC